» Articles » PMID: 35191116

Clinical Exome Sequencing-Mistakes and Caveats

Overview
Journal Hum Mutat
Specialty Genetics
Date 2022 Feb 22
PMID 35191116
Authors
Affiliations
Soon will be listed here.
Abstract

Massive parallel sequencing technology has become the predominant technique for genetic diagnostics and research. Many genetic laboratories have wrestled with the challenges of setting up genetic testing workflows based on a completely new technology. The learning curve we went through as a laboratory was accompanied by growing pains while we gained new knowledge and expertise. Here we discuss some important mistakes that have been made in our laboratory through 10 years of clinical exome sequencing but that have given us important new insights on how to adapt our working methods. We provide these examples and the lessons that we learned to help other laboratories avoid to make the same mistakes.

Citing Articles

HiFi long-read genomes for difficult-to-detect, clinically relevant variants.

Hops W, Weiss M, Derks R, Galbany J, Ouden A, van den Heuvel S Am J Hum Genet. 2025; 112(2):450-456.

PMID: 39809270 PMC: 11866944. DOI: 10.1016/j.ajhg.2024.12.013.


Genomic Insights into Idiopathic Granulomatous Mastitis through Whole-Exome Sequencing: A Case Report of Eight Patients.

Ong S, Ho P, Khng A, Tan B, Tan Q, Tan E Int J Mol Sci. 2024; 25(16).

PMID: 39201744 PMC: 11354296. DOI: 10.3390/ijms25169058.


Principles of clinical genetics for rheumatologists: clinical indications and interpretation of broad-based genetic testing.

do Nascimento R, Quaio C, Chung C, de Moraes Vasconcelos D, Sztajnbok F, Neto N Adv Rheumatol. 2024; 64(1):59.

PMID: 39143637 DOI: 10.1186/s42358-024-00400-z.


Utility of genome sequencing in exome-negative pediatric patients with neurodevelopmental phenotypes.

Nomakuchi T, Teferedegn E, Li D, Muirhead K, Dubbs H, Leonard J Am J Med Genet A. 2024; 194(12):e63817.

PMID: 39031459 PMC: 11540733. DOI: 10.1002/ajmg.a.63817.


Quality assurance for next-generation sequencing diagnostics of rare neurological diseases in the European Reference Network.

Maver A, Lohmann K, Borovecki F, Wolstenholme N, Taylor R, Spielmann M Eur J Hum Genet. 2024; 32(8):1014-1021.

PMID: 38839988 PMC: 11292006. DOI: 10.1038/s41431-024-01639-2.


References
1.
Menke L, Gardeitchik T, Hammond P, Heimdal K, Houge G, Hufnagel S . Further delineation of an entity caused by CREBBP and EP300 mutations but not resembling Rubinstein-Taybi syndrome. Am J Med Genet A. 2018; 176(4):862-876. DOI: 10.1002/ajmg.a.38626. View

2.
Santani A, Simen B, Briggs M, Lebo M, Merker J, Nikiforova M . Designing and Implementing NGS Tests for Inherited Disorders: A Practical Framework with Step-by-Step Guidance for Clinical Laboratories. J Mol Diagn. 2019; 21(3):369-374. DOI: 10.1016/j.jmoldx.2018.11.004. View

3.
Sathirapongsasuti J, Lee H, Horst B, Brunner G, Cochran A, Binder S . Exome sequencing-based copy-number variation and loss of heterozygosity detection: ExomeCNV. Bioinformatics. 2011; 27(19):2648-54. PMC: 3179661. DOI: 10.1093/bioinformatics/btr462. View

4.
Nikitina T, Kashevarova A, Gridina M, Lopatkina M, Khabarova A, Yakovleva Y . Complex biology of constitutional ring chromosomes structure and (in)stability revealed by somatic cell reprogramming. Sci Rep. 2021; 11(1):4325. PMC: 7900208. DOI: 10.1038/s41598-021-83399-3. View

5.
Huang C, Schneider A, Lu Y, Niranjan T, Shen P, Robinson M . Mobile interspersed repeats are major structural variants in the human genome. Cell. 2010; 141(7):1171-82. PMC: 2943426. DOI: 10.1016/j.cell.2010.05.026. View